Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you but can't take credit. Someone posted it on ST but no one seemed to take notice. I verified and thought I'd post here.
Always enjoyed your posts and insight. Been invested in SYN for some time but I don't post often.
Thank you again for your contributions.
The SYN-004 PPI trial now shows as completed as of April 20th on the clinicaltrials.gov site.
Stock twits and Goldman Sachs.
ST is posting that GS has officially dropped coverage of MNKD. Very interesting....
Just a brief, few second mention of the implant. A woman who was addicted to pain killers participated in a "clinical trial" using an implant to control her addiction . More details than that but it was very short
Believe it or not we got a brief mention on NBC national news tonight in their story on prescription opioid drug abuse.
Well said and definitely agree.
004 is in phase 2a testing in presence with ppi and in a 2b trial that will enroll 375 or so patients. First interim analysis will be at 120 patients for that 2b trial. There are no phase 3 trials started for 004 or 010.
I thought the p2a ppi data was due end of q1. Maybe interim 004 2b data (120 patients I think is the threshold for interim) by end of q1 but not sure they put a timeframe on it.
Not that I want to make you another 3 cents but these suits are filed all the time and never progress or or are responded to. Best of luck to you and your "no position".
Not really....if there are no plaintiffs, there's no case....which is why these generally go away....but best of luck to you.
How is Viebacher involved in this?
Not too worried about 173k shares. I believe someone on another board calculated it out to be .0003 % of outstanding shares.
I agree and hope you're right :)
Incredible option volume today....
Excellent point and I agree with you.
Well said :)
I agree
Amazing slide.....
Thank you, Liz, for clarifying. It's greatly appreciated.
I was trying not to get caught up in that "industry" either but had to ask.
Regards,
Chris
Ditto :). In at .74
Thank you for posting, C. I wonder if this is why the results are still pending. In that, if she has just received hers, there may be others who are waiting to recurve theirs as well before data can be released.
Just thinking out loud...
Has anyone seen the change in trial end date for 010 phase 2 on clinical trials site? It was q1 2016 and now it's September 2015.
Lol!! Oh my. Best of luck, Denise.
I just noticed something today. In the 8k for the intrexon agreement, in section 3.9 "third Party Licenses", an entity name is redacted. It's not Synthetic or Intrexon as they are mentioned in the same clauses.
Anyone have any thoughts? Not trying to pump here just interested in others' perspectives.
That is just amazing. :)
Thoughts on today's 8k filing anyone?
Wow. Already 1.1 MM shares traded...
Ok newbie question time....what happens to options in a RS situation?
Well said, Ann. Great to see you posting again. :)
Long SYN
Completely agree with you and thank you for your posts. Always informative and great reads....
Glad to have you back in, Bob.
13.3 M shares at $3 per share. Just released.
Happy 4th everyone!!!
1000% agree. :)
Yep. Just watching and waiting. :)
Well said!!! Thanks Ann and best of luck!!
New PR...12u approved by FDA on 4/17 and manufacturing will begin.
That's very nice of you to do that. Thank you.
Me either....